DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20161291

Maternal and fetal outcome in antepartum haemorrhage: a study at tertiary care hospital

Kshama Kedar, Prashant Uikey, Ashwini Pawar, Anuja Choudhary

Abstract


Background: Antepartum hemorrhage (APH) complicates about 2-5% of pregnancies. Maternal and perinatal morbidity and mortality associated with APH can be reduced significantly by aggressive expectant management. The objective was to study the maternal and fetal outcome in APH and to assess the importance of early diagnosis and treatment

Methods: This prospective study was conducted in the department of OBGY in IGGMC Nagpur from Dec 2013 to Nov.15. 131 cases of APH with gestational age >28 weeks were included. They were distributed according to type of APH into Abruptio Placentae (AP), Placenta Previa (PP) and Unclassified Haemorrhage (UH). Causes of APH were noted and maternal as well as perinatal outcome observed.

Results: Out of 131, 51.91% was AP followed by PP (45.80%) and 2.29% of UH. Maximum patients belonged to 25 to 29 years age group (40.46%), which was statistically significant (p value 0.023). Maximum no. of patients who presented with APH was of more than 36 weeks of gestational age which was statistically significant (p value 0.0001). 52.94% had PIH as a causative factor of abruption while 41.67% had history of previous LSCS for PP. Anaemia was most common complication in APH followed by PPH. One patient died of renal failure in AP. Neonatal jaundice was the most common complication amongst the neonate followed by prematurity.

Conclusions: Prevalence of APH was 2% with AP being most common cause followed by PP. Though maternal morbidity is reduced with modern management of APH, but timely diagnosis and intervention is necessary.


Keywords


Antepartum haemorrhage, Abruptio placentae, Placenta previa

Full Text:

PDF

References


Crane JMG, Van Den Hof MC, Dodds L, Armson BA, Liston R. Neonatal outcomes with placenta previa. Obstetr Gynecol. 1999;93:541-4.

Frederiksen MC, Glassenberg R, Stika CS: Placenta previa: a 22-years analysis. Am J Obstetr Gynecol. 1999;180:1432.

Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: A meta-analysis of observational studies. Obstetr Gynecol. 1999;93:622-8.

Cunningham F, Leveno K, Bloom S, Hauth J, Gilstrap L, Rouse D et al. Obstetrical haemorrhage. Williams Obstetrics. 23rd Edition, New York, McGraw Hill Professionals;2009.

Park K. Maternal and child health. In: Park’s textbook of preventive and social medicine. 17th edition. Banarasi Das Bhanot ’Jabalpur; 2000.

Dutta DC. Antepartum haemorrhage. In: Hiralal Konar, editor. Textbook of obstetrics. 6th edition. New Central Book Agency, Calcutta; 2004:243-61.

Amoma AB, Augerea L, Klufio CA. Late pregnancy bleeding. PNG Med J. 1992;3517.

Chakraborty B De KC, Evaluation of third trimester bleeding with reference to maternal and perinatal outcome. J Obstetr Gynecol India. 1993;42:166-71.

Taylor VM, Peacock S, Kramer MD, Vaughan TL. Increased risk of placenta previa among women of Asian origin. Obstetr Gynecol. 1995;86(5):805-8.

Rai L, Duvvi H, Rao UR, Vaidehi, Nalinii V. Severe abruptio placentae Still unpreventable Int J Gynecol Obstetr. 1989;29:117.

Baskette TF. Grand multiparity- a continuing threat: a 6 year review. Can Med Assoc J. 1997;116:1001.

Pedowitz P. Placenata previa; an evaluation of expectant management and the factors responsible for fetal wastage. An J Obstetr & Gynecol. 1965;93:16-25.

Das B. Antepartum haemorrhage in three decades. J Obstetr &Gynecol India. 1975:25:636-7.

Ananth CV, Wilcox AJ, Savitz DA, Bowes WA Jr, Luther ER. Effect of maternal age and parity on the risk of uteroplacental bleeding disorders in pregnancy. Obstetr & Gynecol. 1996;88(4 Pt 1):511-6.

William MA, Mittendorf R. Increasing maternal age, a determinant for placenta previa more important than increasing parity. PJ Report Med. 1993;38:425-8.

Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstetr Gynecol. 1980;137:687.

Crenshaw C Jr, Jones DE, Parker RT. Placenta previa: a survey of twenty years experience with improved perinatal survival by expectant 119 therapy and Cesarean delivery. Obstetr Gynecol Surv. 1973;28(7):461-70.

Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? a systematic review. Eur J Obstetrics & Gynecology Reprod Biol. 2002;101:6-14.

Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean deliveries and higher parity. Obstetr & Gynecol. 2002;99:976.

Hibbard BM, Jeffcoate TNA. Abruptio Placentae. Obstetr Gynecol. 1966;27:155-67.

Major CA, de Veciana M, Lewis DF, Morgan MA. Preterm premature rupture of membranes and abruptio placentae: Is there an association between these pregnancy complications? Am J Obstetrics & Gynecol. 1995;172:672-6.

Kayani SI, Walkinshaw SA, Preston C. Pregnancy outcome in severe placental abruption. Br J Obstetr Gynaecol. 2003;110:679-83.

Mc Shane SP, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstetr & Gynecol. 1985;65:176-81.

Gorodeski IG. Bahari CM. Schachter A, Neri A. Recurrent placenta previa. Eur J Obstetr Gynecol Reprod Biol. 1981;12(1):7-11.